Pentazocine analgesia and regional rat brain catecholamines.
D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D001921:Brain / Q000201:enzymology; D001923:Brain Chemistry / Q000187:drug effects*; D002395:Catecholamines / Q000378:metabolism*; D002540:Cerebral Cortex / Q000187:drug effects; D003342:Corpus Striatum / Q000187:drug effects; D004027:Diencephalon / Q000187:drug effects; D004299:Dopamine beta-Hydroxylase / Q000037:antagonists & inhibitors; D004305:Dose-Response Relationship, Drug; D004558:Electric Stimulation; D006624:Hippocampus / Q000187:drug effects; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects; D010423:Pentazocine / Q000494:pharmacology*; D010919:Placebos; D051381:Rats; D013223:Statistics as Topic; D013687:Telencephalon / Q000187:drug effects; D014446:Tyrosine 3-Monooxygenase / Q000037:antagonists & inhibitors; D014828:Vocalization, Animal / Q000187:drug effects
D000700:Analgesics; D002395:Catecholamines; D008781:Methyltyrosines; D010919:Placebos; D014446:Tyrosine 3-Monooxygenase; D004299:Dopamine beta-Hydroxylase; D010423:Pentazocine